QSAR Modeling: Where Have You Been? Where Are You Going To?
Top Cited Papers
- 18 December 2013
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 57 (12) , 4977-5010
Abstract
Quantitative structure–activity relationship modeling is one of the major computational tools employed in medicinal chemistry. However, throughout its entire history it has drawn both praise and criticism concerning its reliability, limitations, successes, and failures. In this paper, we discuss (i) the development and evolution of QSAR; (ii) the current trends, unsolved problems, and pressing challenges; and (iii) several novel and emerging applications of QSAR modeling. Throughout this discussion, we provide guidelines for QSAR development, validation, and application, which are summarized in best practices for building rigorously validated and externally predictive QSAR models. We hope that this Perspective will help communications between computational and experimental chemists toward collaborative development and use of QSAR models. We also believe that the guidelines presented here will help journal editors and reviewers apply more stringent scientific standards to manuscripts reporting new QSAR studies, as well as encourage the use of high quality, validated QSARs for regulatory decision making.Keywords
This publication has 266 references indexed in Scilit:
- Iterative Refinement of a Binding Pocket Model: Active Computational Steering of Lead OptimizationJournal of Medicinal Chemistry, 2012
- Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and MechanismsJournal of Chemical Information and Modeling, 2012
- The inevitable QSAR renaissanceJournal of Computer-Aided Molecular Design, 2011
- NanoParticle Ontology for cancer nanotechnology researchJournal of Biomedical Informatics, 2011
- Rethinking 3D-QSARJournal of Computer-Aided Molecular Design, 2010
- Development, Validation, and Use of Quantitative Structure−Activity Relationship Models of 5-Hydroxytryptamine (2B) Receptor Ligands to Identify Novel Receptor Binders and Putative Valvulopathic Compounds among Common DrugsJournal of Medicinal Chemistry, 2010
- Quantitative Nanostructure−Activity Relationship ModelingACS Nano, 2010
- Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling ResearchJournal of Chemical Information and Modeling, 2010
- Predicting new molecular targets for known drugsNature, 2009
- Affinity of Drugs and Small Biologically Active Molecules to Carbon Nanotubes: A Pharmacodynamics and Nanotoxicity Factor?Molecular Pharmaceutics, 2009